Ferumoxytol Can Be Used for Quantitative Magnetic Particle Imaging of Transplanted Stem Cells
- 290 Downloads
To evaluate, if clinically translatable ferumoxytol nanoparticles can be used for in vivo detection and quantification of stem cell transplants with magnetic particle imaging (MPI).
Mesenchymal stem cells (MSCs) were labeled with ferumoxytol or ferucarbotran and underwent MPI, magnetic resonance imaging (MRI), Prussian blue staining, and inductively coupled plasma (ICP) spectrometry. Unlabeled, ferumoxytol, and ferucarbotran-labeled MSCs were implanted in calvarial defects of eight mice and underwent MPI, MRI, and histopathology. The iron concentration calculated according to the MPI signal intensity and T2 relaxation times of the three different groups were compared using an analysis of variance (ANOVA) with Bonferroni correction, and a p < 0.05.
Compared to unlabeled controls, ferumoxytol- and ferucarbotran-labeled MSC showed significantly increased iron content, MPI signal and MRI signal. The ferumoxytol MPI signal was approximately 4× weaker compared to ferucarbotran at equimolar concentrations (p = 0.0003) and approximately 1.5× weaker for labeled cells when using optimized labeling protocols (p = 0.002). In vivo, the MPI signal of ferumoxytol-labeled MSC decreased significantly between day 1 and day 14 (p = 0.0124). This was confirmed by histopathology where we observed a decrease in Prussian blue stain of MSCs at the transplant site. The MRI signal of the same transplants did not change significantly during this observation period (p = 0.93).
Ferumoxytol nanoparticles can be used for in vivo detection of stem cell transplants with MPI and provide quantitative information not attainable with MRI.
Key WordsStem cell MRI MPI Molecular imaging
This work was supported by a grant from the Musculoskeletal Transplant Foundation and a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant no. 4R01AR054458-09.
Compliance with Ethical Standards
Conflict of Interest
Prachi Pandit holds equity interest in Magnetic Insight Inc.
- 5.Buza JA 3rd, Einhorn T (2016) Bone healing in 2016. Clin Cases Miner Bone Metab 13:101–105Google Scholar
- 11.Hyun J, Grova M, Nejadnik H, Lo D, Morrison S, Montoro D, Chung M, Zimmermann A, Walmsley GG, Lee M, Daldrup-Link H, Wan DC, Longaker MT (2013) Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector. Stem Cells Transl Med 2:690–702CrossRefGoogle Scholar
- 16.Netto JP, Iliff J, Stanimirovic D, Krohn KA, Hamilton B, Varallyay C, Gahramanov S, Daldrup-Link H, d’Esterre C, Zlokovic B, Sair H, Lee Y, Taheri S, Jain R, Panigrahy A, Reich DS, Drewes LR, Castillo M, Neuwelt EA (2018) Neurovascular unit: basic and clinical imaging with emphasis on advantages of ferumoxytol. Neurosurgery 82:770–780CrossRefGoogle Scholar
- 19.Castaneda RT, Khurana A, Khan R, Daldrup-Link HE (2011) Labeling stem cells with ferumoxytol, an FDA-approved Iron oxide nanoparticle. J Visualized Exp. https://doi.org/10.3791/3482
- 24.Wang Y-XJ (2011) Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 1:35–40Google Scholar
- 26.VivoTrax™ Super-paramagnetic iron oxide tracer for pre-clinical Magnetic Resonance and Magnetic Particle Imaging. https://www.magneticinsight.com/vivotrax/ (accessed 12/20/2017)
- 29.Panagiotopoulos N, Duschka RL, Ahlborg M, Bringout G, Debbeler C, Graeser M, Kaethner C, Lüdtke-Buzug K, Medimagh H, Stelzner J, Buzug TM, Barkhausen J, Vogt FM, Haegele J (2015) Magnetic particle imaging: current developments and future directions. Int J Nanomedicine 10:3097–3114CrossRefGoogle Scholar
- 30.Mason EE, Cooley CZ, Cauley SF et al (2017) Design analysis of an MPI human functional brain scanner. Int J Magn Part Imaging 3. https://doi.org/10.18416/ijmpi.2017.1703008
- 32.Daldrup-Link HE, Chan C, Lenkov O, Taghavigarmestani S, Nazekati T, Nejadnik H, Chapelin F, Khurana A, Tong X, Yang F, Pisani L, Longaker M, Gambhir SS (2017) Detection of stem cell transplant rejection with ferumoxytol MR imaging: correlation of MR imaging findings with those at Intravital microscopy. Radiology 284:495–507CrossRefGoogle Scholar
- 35.Tromsdorf UI, Bigall NC, Kaul MG, Bruns OT, Nikolic MS, Mollwitz B, Sperling RA, Reimer R, Hohenberg H, Parak WJ, Förster S, Beisiegel U, Adam G, Weller H (2007) Size and surface effects on the MRI Relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett 7:2422–2427CrossRefGoogle Scholar
- 39.Tay ZHD, et al. (2017) Eight fold improvement in magnetic particle imaging resolution with pulsed drive waveform. [Abstract]Google Scholar
- 41.Lu KGP, Zheng B, Conolly S. (2017) Multi-channel Acquisition for Isotropic Resolution in Magnetic Particle Imaging. [abstract]. 1PGoogle Scholar
- 43.Lu KGP, Zheng B, Conolly S (2015) Reshaping the 2D MPI PSF to be isotropic and sharp using vector acquisition and equalization [abstract]. 1PGoogle Scholar
- 44.Khurana A, Chapelin F, Beck G, Lenkov OD, Donig J, Nejadnik H, Messing S, Derugin N, Chan RCF, Gaur A, Sennino B, McDonald DM, Kempen PJ, Tikhomirov GA, Rao J, Daldrup-Link HE (2013) Iron administration before stem cell harvest enables MR imaging tracking after transplantation. Radiology 269:186–197CrossRefGoogle Scholar
- 45.Aghighi M, Theruvath AJ, Pareek A, Pisani LL, Alford R, Muehe AM, Sethi TK, Holdsworth SJ, Hazard FK, Gratzinger D, Luna-Fineman S, Advani R, Spunt SL, Daldrup-Link HE (2018) Magnetic resonance imaging of tumor associated macrophages: clinical translation. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-18-0673